学会発表など
Inoue S, Kobayashi M, Pang F. AN ECONOMIC EVALUATION OF MIGALASTAT VERSUS ERT FOR THE TREATMENT OF FABRY DISEASE IN JAPAN. ISPOR Asia-Pacific Conference, Tokyo, Japan. Poster Presentation. Sep 10, 2018.
Kamae I, Kitamura A, Sakurai M, Yamamoto M, Inoue S, Shibahara H,Kobayashi M. ECONOMIC BURDEN OF ATRIAL FIBRILLATION IN JAPAN. ISPOR Asia-Pacific Conference, Tokyo, Japan. Poster Presentation. Sep 9, 2018.
Kitamura A, Sato T, Priest V, Inoue S,Kobayashi M. COST-MINIMIZATION ANALYSIS OF VERCISE DBS SYSTEM FOR PARKINSON’S DISEASE IN JAPAN. ISPOR Asia-Pacific Conference, Tokyo, Japan. Poster Presentation. Sep 9, 2018.
Kamae I, Kobayashi M, Patel P, Neumann PJ. Japanese HTA and Pricing: Current Methods and Future Potential. ISPOR Asia-Pacific Conference, Tokyo, Japan. Workshop Presentation. Sep 10, 2018.
Ikeda S, Kobayashi M, Wong-Rieger D. How Will Patient Centricity Be Captured in the Japanese HTA and Healthcare Reform? ISPOR Asia-Pacific Conference, Tokyo, Japan. Issue Panel Presentation. Sep 9, 2018.
Kobayashi M, Lee SS, Liu L, Tang B, Xuan J. ADVANCING PATIENT ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES IN ASIA – THE ROLE OF REAL-WORLD DATA IN THE VALUE FRAMEWORK. ISPOR 2018, Baltimore, USA. ISPOR Forum. May 21, 2018.
Kim S, Ko BS, Kobayashi M, Sharma J, Xuan J. REAL-WORLD EVIDENCE AND LOCAL EVIDENCE GENERATION: HOW SHOULD IT BE APPROACHED IN ASIA PACIFIC? ISPOR 2018, Baltimore, USA. ISPOR Forum. May 22, 2018.
村田達教, 鈴鴨よしみ, 白岩健, 下妻晃二郎, 大橋靖雄, 向井博文. 移転・再発乳癌患者対象のタキサン系薬剤とティーエスワンのランダム化比較試験（SELECT-BC）におけるQOLのレスポンスシフト分析. 第5回QOL/PRO研究学術会. 2017年12月2日.
Noto S, Igarashi A, Shiroiwa T, Fukuda T, Ikeda S, Moriwaki K, Saito S, Shimozuma K, Ishida H, Kobayashi M. Reliability And Validity Of Two Proxy Versions Of EQ-5D-5L In Japan. ISPOR 20th Annual European Congress Glasgow, Scotland. Research Poster Presentations. Nov 7, 2017.
Yamabe K, Kuwabara H, Inoue S, Kobayashi M. Burden Of Ulcerative Colitis In Japan. ISPOR 20th Annual European Congress Glasgow, Scotland. Research Poster Presentations. Nov 6, 2017.
